Search Filters
Advanced Search
SMC ID Date Medicine Submission Type Indication
1328/18 11/06/2018 inotuzumab ozogamicin (Besponsa) Full As monotherapy for the treatment of adults with relapsed or refractory CD22-positive B cell precursor acute lymphoblastic leukaemia. Adult patients with Philadelphia chromosome positive relapsed or refractory B cell precursor acute lymphoblastic leukaemia should have failed treated with at least 1 tyrosine kinase inhibitor.

No medicines have been found.